Precision BioSciences shareholders approve 3.8M share increase to equity plan, officer liability limits

Filed May 26, 2026 · Period ending May 21, 2026 · ~1 min read

Key Changes

• medium

  Shareholders approved adding 3.8 million shares to the 2019 equity compensation plan, expanding the pool available for employee stock grants and options. This increases potential shareholder dilution from future equity awards.

  Item 5.03: Equity Plan verify on EDGAR →
• medium

  Charter amendment approved to limit personal liability of certain officers for breaches of fiduciary duty, as permitted under Delaware law. The amendment became effective May 22, 2026.

  Item 5.03: Charter Amendment verify on EDGAR →
• low

  Two Class I directors elected to serve until 2029: Melinda Brown (14.3M votes for) and Geno Germano (14.3M votes for). Both received majority support from shareholders.

  Item 5.07: Director Elections verify on EDGAR →